RecruitingAccepts healthy volunteers
Use of Continuous Glucose Monitors in Children and Adolescents With Obesity
University of California, Los Angeles · NCT06254768
View Study & Apply (opens in a new tab)
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 10–21 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- January 17, 2023
- Record last updated
- February 12, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.
Being studied: Continuous glucose monitor
Conditions: Pediatric Obesity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 10-21 years BMI >95th percentile
Exclusion Criteria
- Previous diagnosis of Prader Willi Syndrome or hypothalamic obesity
- Intellectual disability
- Previous or planned bariatric surgery
- Hemoglobin A1c >6.5 %
- Current use of medication that impacts weight
Recruiting US locations
Pediatric Endocrinology Division, University of California
Los Angeles, CA 90025
Site contact: Sri Nikhita Chimatapu · 917-741-4080 · schimatapu@mednet.ucla.edu
Study contacts (from the official record)
- Sri Nikhita Chimatapu, MD · 9177414080 · schimatapu@mednet.ucla.edu
Similar studies in California
All weight loss studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
TIXiMED, Inc.
- Location
- Chula Vista, CA
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
Regeneron Pharmaceuticals
- Location
- Glendale, CA
- Eligibility basics
- Ages 18–65